Q3 2021 Earnings

Latest Events

Investor Relations

Press Releases

04 Nov '21
Third quarter GAAP diluted EPS of $0.12 ; non-GAAP diluted EPS of $0.27 , up 145% year-over-year Generated $57 million of cash flow from continuing operations and $35 million of free cash flow in the third quarter Increasing 2021 outlook for Adjusted EBITDA and free cash flow CHICAGO --(BUSINESS
21 Oct '21
CHICAGO --(BUSINESS WIRE)--Oct. 21, 2021-- Allscripts Healthcare Solutions, Inc . (Nasdaq:MDRX) will report its financial results for the three months ended September 30, 2021 after the close of stock market hours on Thursday, November 4, 2021 . Allscripts management plans to host a conference call

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Contact Investor Relations

Jenny Gelinas
Vice President, Investor Relations
Jenny.Gelinas@allscripts.com